And I cannot deny that we have failed previously in our efforts to help patients lose weight
Why Effecty
Qsymia (phentermine and topiramate) is an FDA-approved extended-release weight loss medication
Lipohypertrophy, the buildup of fatty tissue at frequently injected sites, becomes a concern with increased injection frequency
Neeland, Linge, and Birkenfeld (2024), writing in Diabetes, Obesity and Metabolism , conclude that skeletal muscle changes with GLP-1 receptor agonist treatment appear adaptive: reductions in muscle volume are commensurate with what is expected given aging, disease status, and weight loss achieved, and improvements in insulin sensitivity and muscle fat infiltration likely contribute to improved muscle quality
Colloquially, these changes are referred to on social media as semaglutide face or Ozempic face, based on the commercial names of semaglutide